Results 181 to 190 of about 14,369,746 (295)

Society for Maternal‐Fetal Medicine Special Statement: Guidance to reduce racial disparities in substance use screening and biological testing in pregnancy at the delivery admission

Pregnancy, Volume 2, Issue 6, November 2026.
Abstract Substance use complicates upward of 10% of US pregnancies. The Society for Maternal‐Fetal Medicine, the American College of Obstetricians and Gynecologists, and the American Society of Addiction Medicine have jointly recommended universal screening for substance use during pregnancy using a validated tool, without recommending universal ...
Society for Maternal‐Fetal Medicine (SMFM), Jennifer J. M. Cate, Samuel T. Bauer, Niraj R. Chavan, Marc Parrish, Jessica Peterson, Dena Goffman, Christina Davidson, SMFM Patient Safety and Quality Committee   +8 more
wiley   +1 more source

Social determinants of health associated with newly documented opioid‐related postpartum readmissions

Pregnancy, Volume 2, Issue 6, November 2026.
Abstract Objective Peripartum opioid‐related mortality has increased in recent years, and social determinants of health (SDOH) are associated with adverse maternal outcomes. We sought to identify risk factors (including SDOH risk factors) for 180‐day postpartum readmissions related to opioid use among individuals without a documented diagnosis of ...
India Perez‐Urbano, Timothy Wen, Yongmei Huang, Alexander Friedman   +3 more
wiley   +1 more source

Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeys. [PDF]

Exp Clin Psychopharmacol, 2020
Lile JA, Johnson AR, Banks ML, Hatton KW, Hays LR, Nicholson KL, Poklis JL, Rayapati AO, Rush CR, Stoops WW, Negus SS.   +10 more
europepmc   +1 more source

Convenient and Sustainable Reduction of β‐Nitrostyrenes

ChemistrySelect, Volume 11, Issue 41, 3 November 2026.
A robust procedure for the synthesis of phenethylamines from the corresponding nitrostyrenes has been developed on multi‐gram scale. Using cheap reagents and green solvents the product is isolated in high yield and purity using a minimum of organic solvents without the need for chromatographic purification.
Christian B. M. Poulie, Adrian G. Rossebø, Jonas K. Hundborg, Emil R. H. Andersen, Birka M. von Holck, Laura M. Lange, Astrid V. Johannsen, Silvia P. Pastor, Jesper L. Kristensen   +8 more
wiley   +1 more source

Differential effects of d-amphetamine and atomoxetine on risk-based decision making of Lewis and Fischer 344 rats. [PDF]

Behav Pharmacol, 2019
Ozga-Hess JE, Anderson KG.
europepmc   +1 more source

Neurophysiological and Behavioural Effects of Combined Cannabis Concentrates and Alcohol Among People Who Regularly Use Alcohol and Cannabis

Addiction Biology, Volume 31, Issue 11, November 2026.
This naturalistic feasibility study explored the effects of alcohol and cannabis co‐intoxication on behavioural performance and brain activity using electroencephalography. A performance monitoring task was administered three times over 4.5‐h at sober, intoxication, and recovery timepoints.
Eleftherios M. Hetelekides, Patricia L. Davies, Mark A. Prince, William J. Gavin, Hollis C. Karoly   +4 more
wiley   +1 more source

Overdose reversal through peer intervention: Findings from the naloxone prospective outcome research study (NalPORS) on the effectiveness of overdose response by people who use opioids in the United Kingdom and Sweden

Addiction, Volume 121, Issue 11, Page 3025-3039, November 2026.
Abstract Background/aims Take‐home naloxone (THN) programmes have been introduced in many European countries to provide non‐medically trained people who are likely to witness an opioid overdose, including people who use opioids, with a naloxone kit and training.
Nicola Metrebian, Teodora Dascal, Clare Mackie, Rose Tinch‐Taylor, Ben Carter, Joanne Neale, Mariana Gonzalez Utrilla, Ed Day, Joar Guterstam, Kirsten Horsburgh, Martin Kåberg, Mike Kelleher, Soraya Mayet, Josie Smith, Desiree Eide, Elin Holmén, Rebecca McDonald, Stephen Parkin, Henrik Thiesen, John Strang, NalPORS Research Team, Dean Acreman, Shabana Akhtar, Louise Aitken, Martin Anderson, James Cassidy, Sarah Cosgrove, Jo Grayer, Michelle Hughes, Louise Horn, Anika Miah, John Pratt   +31 more
wiley   +1 more source

From emergence to replacement: The evolution of 3‐methylmethcathinone (3‐MMC) and its substitutes in the Dutch drug market (2012–2024)

Addiction, Volume 121, Issue 11, Page 3065-3074, November 2026.
Abstract Background and aims The market for new psychoactive substances (NPS) is highly dynamic, with hundreds of substances emerging on the European drug market in the last decade. 3‐methylmethcathinone (3‐MMC), a synthetic cathinone and isomer of mephedrone (4‐MMC), gained popularity in the Netherlands due to its psychostimulant effects and initial ...
Nadia Robert Petronella Wilhelmina Hutten, Pieter Edmond Oomen, Frederiek Schutten, Margriet Walburga van Laar, Laura Alexandra Smit‐Rigter   +4 more
wiley   +1 more source

Investigating Potential Adverse Drug Reactions of Lisdexamfetamine Using Sequence Symmetry Analysis

Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 5, November 2026.
ABSTRACT The prevalence of ADHD is increasing rapidly, and lisdexamfetamine is increasingly popular, but few studies investigate its safety. We performed a sequence symmetry analysis (SSA) using Danish register data to identify potential ADRs associated with lisdexamfetamine in 2013–2023.
Thomas Leth Jensen, Sanne Møller Thysen, Espen Jimenez‐Solem, Anders Jørgensen, Camilla Bjørn Jensen, Hans Kristian Råket, Merete Osler, Mads Nielsen, Lars Christian Lund   +8 more
wiley   +1 more source

Effects of environmental enrichment on d-amphetamine self-administration following nicotine exposure. [PDF]

Exp Clin Psychopharmacol, 2017
Stairs DJ, Ewin SE, Kangiser MM, Pfaff MN.   +3 more
europepmc   +1 more source